Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fight against schizophrenia stigma].

J J López-Ibor Aliño

    Anales De La Real Academia Nacional De Medicina
    |October 20, 2001
    PubMed
    Summary

    Reducing stigma in schizophrenia is crucial for patient outcomes. A pilot program in Madrid successfully reduced discrimination by focusing on patients, families, and healthcare professionals, demonstrating effective anti-stigma strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Risk factor for psycopathology during residency.

    Actas espanolas de psiquiatria·2010
    Same author

    Pharmacological treatment of acute stress disorder with propranolol and hypnotics.

    Actas espanolas de psiquiatria·2007
    Same author

    Juan José López Ibor.

    Actas espanolas de psiquiatria·2007
    Same author

    [Historical review of the borderline personality disorder concept].

    Actas espanolas de psiquiatria·2006
    Same author

    [Atypical anorexia nervosa without body image distortion: based on a clinical case].

    Actas espanolas de psiquiatria·2003
    Same author

    [PET in neurology and psychiatry I. PET with FDG in the study of the CNS].

    Revista espanola de medicina nuclear·2002

    Area of Science:

    • Psychiatry and Mental Health
    • Public Health Campaigns
    • Social Determinants of Health

    Context:

    • Stigma, discrimination, and prejudice against mental illness are pervasive globally.
    • Schizophrenia-related stigma negatively impacts illness detection, treatment adherence, rehabilitation, and social reintegration.
    • Existing societal structures, including families and healthcare systems, perpetuate stigma.

    Purpose:

    • To evaluate the effectiveness of the World Psychiatric Association's (WPA) anti-stigma program for schizophrenia.
    • To identify and address stigma within patient-centric environments (patients, families, healthcare staff).
    • To adapt and implement anti-stigma strategies based on local needs and research.

    Summary:

    • A pilot study in Madrid (1999) initially found low public awareness but significant stigma among patients, relatives, and healthcare professionals.
    • Interventions focused on training professionals and targeted local groups, leading to high satisfaction.
    • A media campaign shifted public discourse from incidental problems to disease-specific information, proving the WPA program's adaptable strategies.

    Impact:

    • Demonstrated the success of tailored, research-based anti-stigma campaigns in reducing discrimination.
    • Showcased significant improvements in patient, family, and physician satisfaction.
    • Provided a replicable model for national anti-stigma efforts, as evidenced by subsequent implementation across Spain.

    Related Experiment Videos